MORPHOSYS AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 73.27 USD | +2.10% |
|
0.00% | +78.71% |
| Jul. 17 | Oxford Biomedica Names New Finance Chief | MT |
| Jul. 17 | K3 Business sees interim revenue decline | AN |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 47.54B | - | |||||
| 41.96B | ||||||
| 41.55B | ||||||
| 30.36B | - | |||||
| 27.61B |
